| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |